MedPath

Study of the safety of hyper immune bovine milk and colostrum against covid-19

Not Applicable
Conditions
Covid-19 viral pneumonia.
Pneumonia due to SARS-associated coronavirus
J12.81
Registration Number
IRCT20200927048849N1
Lead Sponsor
Isfahan university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Signing of consent form of the study
Free of underlying disease
Not having clinical signs of covid-19 infection

Exclusion Criteria

Diseased person
Not having underlying disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of clinical symptoms. Timepoint: From the first day of using until 14 days after that. Method of measurement: Questionnaire through phone interview.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath